United States Healthcare Providers & Services

HCA Healthcare Inc (HCA)

Track

The most recent insider trading activity occurred on February 18, 2026. Several executives, including the CEO, EVP & Chief Legal & Admin Off., and SVP & Controller, engaged in significant sell transactions. The total value of these reported sales exceeds $15 million, with the CEO being the most active seller.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: HCA Exchange: NYS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

McAlevey Michael R

EVP & Chief Legal & Admin Off.

1 sale — total 903,537 USD

Sale 18 Feb 2026

Value US$1,386,967.06 | Price 234.90 | Shares 76,319

Michael R McAlevey

OFFICER

1 sale — total 903,486 USD

Proposed sale 18 Feb 2026

Value US$2,613,356.80 | Price 390.01 | Shares 1,851

Wyatt Christopher F.

SVP & Controller

1 sale — total 2,020,000 USD

Sale 11 Feb 2026

Value US$2,020,000.00 | Price 505.00 | Shares 4,000

Berres Jennifer

SVP & Chief Human Res. Officer

2 sales — total 4,126,950 USD

Sale 11 Feb 2026

Value US$2,109,920.05 | Price 526.16 | Shares 4,010

Sale 11 Feb 2026

Value US$2,017,030.00 | Price 503.00 | Shares 4,010

Jennifer L. Berres

OFFICER

1 sale — total 4,126,950 USD

Proposed sale 11 Feb 2026

Value US$4,126,949.90 | Price 514.58 | Shares 8,020

HAZEN SAMUEL N

CEO

7 sales — total 21,483,275 USD

Sale 3 Feb 2026

Value US$59,661.40 | Price 497.18 | Shares 120

Sale 3 Feb 2026

Value US$2,138,442.04 | Price 498.12 | Shares 4,293

Sale 3 Feb 2026

Value US$2,574,793.73 | Price 498.80 | Shares 5,162

Sale 3 Feb 2026

Value US$3,094,608.93 | Price 500.02 | Shares 6,189

Sale 3 Feb 2026

Value US$3,702,626.21 | Price 500.69 | Shares 7,395

Sale 3 Feb 2026

Value US$2,511,756.80 | Price 502.15 | Shares 5,002

Sale 3 Feb 2026

Value US$7,401,385.71 | Price 502.95 | Shares 14,716

Cuffe Michael S.

EVP and Chief Clinical Officer

1 sale — total 747,135 USD

Sale 3 Feb 2026

Value US$747,135.15 | Price 498.09 | Shares 1,500

MICHAEL S CUFFE

OFFICER

1 sale — total 747,135 USD

Proposed sale 3 Feb 2026

Value US$747,135.15 | Price 498.09 | Shares 1,500

Samuel N. Hazen

President, Chief Executive Officer & Director

1 sale — total 21,483,274 USD

Proposed sale 3 Feb 2026

Value US$21,483,273.66 | Price 501.04 | Shares 42,877

Michael R McAlevey

OFFICER

1 sale — total 1,843,991 USD

Proposed sale 5 Nov 2025

Value US$1,843,990.68 | Price 473.79 | Shares 3,892

McAlevey Michael R

EVP & Chief Legal & Admin Off.

1 sale — total 1,843,991 USD

Sale 5 Nov 2025

Value US$1,843,990.68 | Price 473.79 | Shares 3,892

Cuffe Michael S.

Officer

2 sales — total 3,213,340 USD

Proposed sale 8 Sep 2025

Value US$1,606,670.20 | Price 418.84 | Shares 3,836

Planned sale 8 Sep 2025

Value US$1,606,670.24 | Price 418.84 | Shares 3,836

Foster Jon M

EVP and COO

2 sales — total 11,595,321 USD

Sale 13 May 2025

Value US$5,797,660.71 | Price 369.32 | Shares 15,698

Proposed sale 13 May 2025

Value US$5,797,660.00 | Price 369.32 | Shares 15,698

Berres Jennifer

SVP & Chief Human Res. Officer

3 sales — total 6,150,479 USD

Sale 14 Feb 2025

Value US$1,733,362.21 | Price 322.31 | Shares 5,378

Sale 14 Feb 2025

Value US$1,341,878.02 | Price 322.96 | Shares 4,155

Proposed sale 14 Feb 2025

Value US$3,075,238.33 | Price 322.59 | Shares 9,533

Reiner Deborah M

Former Officer

1 sale — total 1,131,589 USD

Proposed sale 11 Feb 2025

Value US$1,131,588.90 | Price 322.39 | Shares 3,510

Whalen Kathleen M

Former Officer

1 sale — total 1,082,203 USD

Proposed sale 31 Jan 2025

Value US$1,082,203.14 | Price 335.26 | Shares 3,228

Whalen Kathleen M

SVP & Chief Ethics Officer

2 sales — total 1,055,355 USD

Sale 14 Nov 2024

Value US$527,677.26 | Price 357.99 | Shares 1,474

Proposed sale 14 Nov 2024

Value US$527,677.26 | Price 357.99 | Shares 1,474

Akdamar Erol R

Officer

2 sales — total 2,767,180 USD

Proposed sale 14 Nov 2024

Value US$1,743,480.00 | Price 357.86 | Shares 4,872

Sale 14 Nov 2024

Value US$1,023,700.00 | Price 353.00 | Shares 2,900

Billington Phillip G

Officer

2 sales — total 2,727,900 USD

Proposed sale 14 Nov 2024

Value US$1,363,950.00 | Price 350.00 | Shares 3,897

Planned sale 14 Nov 2024

Value US$1,363,950.00 | Price 350.00 | Shares 3,897

Cuffe Michael S.

Officer

2 sales — total 6,442,681 USD

Proposed sale 12 Sep 2024

Value US$3,221,340.36 | Price 385.42 | Shares 8,358

Planned sale 12 Sep 2024

Value US$3,221,340.36 | Price 385.42 | Shares 8,358

Whalen Kathleen M

Officer

2 sales — total 2,171,609 USD

Proposed sale 31 Jul 2024

Value US$1,085,804.37 | Price 363.51 | Shares 2,987

Sale 31 Jul 2024

Value US$1,085,804.37 | Price 363.51 | Shares 2,987

Whalen Kathleen M

SVP & Chief Ethics Officer

2 sales — total 1,341,782 USD

Sale 29 Jul 2024

Value US$670,890.88 | Price 359.92 | Shares 1,864

Proposed sale 29 Jul 2024

Value US$670,890.88 | Price 359.92 | Shares 1,864

Reiner Deborah M

SVP - Mktg. & Communications

2 sales — total 2,385,829 USD

Sale 29 Jul 2024

Value US$1,192,914.40 | Price 359.96 | Shares 3,314

Proposed sale 29 Jul 2024

Value US$1,192,914.40 | Price 359.96 | Shares 3,314

Wyatt Christopher F.

Officer

2 sales — total 2,881,565 USD

Proposed sale 29 Jul 2024

Value US$1,440,783.00 | Price 360.20 | Shares 4,000

Sale 29 Jul 2024

Value US$1,440,782.40 | Price 360.20 | Shares 4,000

Torres Kathryn A.

SVP-Payer Contracting & Align.

2 sales — total 1,318,656 USD

Sale 25 Jul 2024

Value US$659,327.85 | Price 355.05 | Shares 1,857

Proposed sale 25 Jul 2024

Value US$659,327.85 | Price 355.05 | Shares 1,857

Whalen Kathleen M

SVP & Chief Ethics Officer

2 sales — total 2,090,930 USD

Sale 16 May 2024

Value US$1,045,465.20 | Price 326.30 | Shares 3,204

Proposed sale 16 May 2024

Value US$1,045,465.20 | Price 326.30 | Shares 3,204

Torres Kathryn A.

SVP-Payer Contracting & Align.

2 sales — total 1,215,346 USD

Sale 15 May 2024

Value US$607,673.15 | Price 326.18 | Shares 1,863

Proposed sale 15 May 2024

Value US$607,673.24 | Price 326.18 | Shares 1,863

Cohen Jeffrey E.

SVP-Government Relations

2 sales — total 1,032,900 USD

Sale 9 May 2024

Value US$516,450.00 | Price 313.00 | Shares 1,650

Proposed sale 9 May 2024

Value US$516,450.00 | Price 313.00 | Shares 1,650

Cuffe Michael S.

EVP and Chief Clinical Officer

2 sales — total 3,999,649 USD

Sale 9 May 2024

Value US$1,999,824.63 | Price 316.88 | Shares 6,311

Proposed sale 9 May 2024

Value US$1,999,824.47 | Price 316.88 | Shares 6,311

RUTHERFORD BILL B

Former Officer

1 sale — total 4,670,373 USD

Proposed sale 7 May 2024

Value US$4,670,372.57 | Price 311.36 | Shares 15,000

Cuffe Michael S.

EVP and Chief Clinical Officer

2 sales — total 988,800 USD

Planned sale 6 May 2024

Value US$494,400.00 | Price 309.00 | Shares 1,600

Proposed sale 6 May 2024

Value US$494,400.00 | Price 309.00 | Shares 1,600

Torres Kathryn A.

SVP-Payer Contracting & Align.

1 sale — total 277,680 USD

Sale 3 May 2024

Value US$277,680.00 | Price 312.00 | Shares 890

Torres Kathryn A.

SVP-Payer Contracting & Align.

2 sales — total 884,832 USD

Sale 2 May 2024

Value US$303,576.00 | Price 312.00 | Shares 973

Proposed sale 2 May 2024

Value US$581,256.00 | Price 312.00 | Shares 1,863

Wasserman Chad J

Officer

2 sales — total 578,598 USD

Proposed sale 20 Mar 2024

Value US$289,299.00 | Price 330.25 | Shares 876

Planned sale 20 Mar 2024

Value US$289,299.00 | Price 330.25 | Shares 876

Wasserman Chad J

SVP and CIO

2 sales — total 221,515 USD

Planned sale 18 Mar 2024

Value US$110,757.68 | Price 321.97 | Shares 344

Proposed sale 18 Mar 2024

Value US$110,757.68 | Price 321.97 | Shares 344

Whalen Kathleen M

SVP & Chief Ethics Officer

2 sales — total 2,610,148 USD

Sale 9 Feb 2024

Value US$1,305,074.27 | Price 306.21 | Shares 4,262

Proposed sale 9 Feb 2024

Value US$1,305,074.09 | Price 306.21 | Shares 4,262

RUTHERFORD BILL B

Officer

2 sales — total 3,727,560 USD

Proposed sale 6 Feb 2024

Value US$1,863,780.00 | Price 310.63 | Shares 6,000

Sale 6 Feb 2024

Value US$1,863,780.00 | Price 310.63 | Shares 6,000

Wyatt Christopher F.

SVP & Controller

2 sales — total 2,499,360 USD

Sale 5 Feb 2024

Value US$1,249,680.00 | Price 312.42 | Shares 4,000

Proposed sale 5 Feb 2024

Value US$1,249,680.00 | Price 312.42 | Shares 4,000

Mosier Sammie S

SVP & Chief Nurse Executive

2 sales — total 1,026,480 USD

Sale 5 Feb 2024

Value US$513,240.00 | Price 312.00 | Shares 1,645

Proposed sale 5 Feb 2024

Value US$513,240.00 | Price 312.00 | Shares 1,645

Wasserman Chad J

SVP and CIO

2 sales — total 406,901 USD

Planned sale 2 Feb 2024

Value US$203,450.54 | Price 312.04 | Shares 652

Proposed sale 2 Feb 2024

Value US$203,450.53 | Price 312.04 | Shares 652

Cuffe Michael S.

EVP and Chief Clinical Officer

1 sale — total 981,734 USD

Planned sale 31 Jan 2024

Value US$981,733.76 | Price 306.79 | Shares 3,200

Torres Kathryn A.

SVP-Payer Contracting & Align.

1 sale — total 1,185,327 USD

Sale 31 Jan 2024

Value US$1,185,327.00 | Price 307.00 | Shares 3,861

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-02-18	2026-02-18	S Sale	2.5 McAlevey Michael R EVP & Chief Legal & Admin Off. Officer	76,319 +14.1% 234.90 US$1,386,967	76,319 +14.1%	234.90	US$1,386,967
2026-02-18	2026-02-18	PrS Proposed sale	2.5 Michael R McAlevey OFFICER Officer	1,851 390.01 US$2,613,357	1,851	390.01	US$2,613,357
2026-02-12	2026-02-11	S Sale	2.9 Wyatt Christopher F. SVP & Controller Officer	91,992 +40.1% 165.71 US$1,728,387	91,992 +40.1%	165.71	US$1,728,387
2026-02-12	2026-02-11	S Sale	2.7 Berres Jennifer SVP & Chief Human Res. Officer Officer	4,010 -25.1% 526.16 US$2,109,920	4,010 -25.1%	526.16	US$2,109,920
2026-02-12	2026-02-11	S Sale	2.7 Berres Jennifer SVP & Chief Human Res. Officer Officer	4,010 -20.0% 503.00 US$2,017,030	4,010 -20.0%	503.00	US$2,017,030
2026-02-11	2026-02-11	PrS Proposed sale	2.7 Jennifer L. Berres OFFICER Officer	8,020 514.58 US$4,126,950	8,020	514.58	US$4,126,950
2026-02-05	2026-02-03	S Sale	2.5 HAZEN SAMUEL N CEO Executive Director	120 -0.4% 497.18 US$59,661	120 -0.4%	497.18	US$59,661
2026-02-05	2026-02-03	S Sale	2.5 HAZEN SAMUEL N CEO Executive Director	4,293 -11.7% 498.12 US$2,138,442	4,293 -11.7%	498.12	US$2,138,442
2026-02-05	2026-02-03	S Sale	2.5 HAZEN SAMUEL N CEO Executive Director	5,162 -12.3% 498.80 US$2,574,794	5,162 -12.3%	498.80	US$2,574,794
2026-02-05	2026-02-03	S Sale	2.5 HAZEN SAMUEL N CEO Executive Director	6,189 -12.9% 500.02 US$3,094,609	6,189 -12.9%	500.02	US$3,094,609
2026-02-05	2026-02-03	S Sale	2.5 HAZEN SAMUEL N CEO Executive Director	7,395 -13.3% 500.69 US$3,702,626	7,395 -13.3%	500.69	US$3,702,626
2026-02-05	2026-02-03	S Sale	2.5 HAZEN SAMUEL N CEO Executive Director	5,002 -8.3% 502.15 US$2,511,757	5,002 -8.3%	502.15	US$2,511,757
2026-02-05	2026-02-03	S Sale	2.5 HAZEN SAMUEL N CEO Executive Director	14,716 -19.6% 502.95 US$7,401,386	14,716 -19.6%	502.95	US$7,401,386
2026-02-05	2026-02-03	S Sale	2.8 Cuffe Michael S. EVP and Chief Clinical Officer Officer	1,500 -4.8% 498.09 US$747,135	1,500 -4.8%	498.09	US$747,135
2026-02-03	2026-02-03	PrS Proposed sale	2.8 MICHAEL S CUFFE OFFICER Officer	1,500 498.09 US$747,135	1,500	498.09	US$747,135
2026-02-03	2026-02-03	PrS Proposed sale	2.5 Samuel N. Hazen President, Chief Executive Officer & Director Executive Director	42,877 501.04 US$21,483,274	42,877	501.04	US$21,483,274
2025-11-05	2025-11-05	PrS Proposed sale	2.5 Michael R McAlevey OFFICER Officer	3,892 473.79 US$1,843,991	3,892	473.79	US$1,843,991
2025-11-05	2025-11-05	S Sale	2.5 McAlevey Michael R EVP & Chief Legal & Admin Off. Officer	3,892 -52.7% 473.79 US$1,843,991	3,892 -52.7%	473.79	US$1,843,991
2025-09-08	2025-09-08	PrS Proposed sale	2.8 Cuffe Michael S. Officer Officer	3,836 418.84 US$1,606,670	3,836	418.84	US$1,606,670
2025-09-08	2025-09-08	PlS Planned sale	2.8 Cuffe Michael S. EVP and Chief Clinical Officer Officer	3,836 -10.9% 418.84 US$1,606,670	3,836 -10.9%	418.84	US$1,606,670
2025-05-15	2025-05-13	S Sale	2.5 Foster Jon M EVP and COO Officer	15,698 -55.4% 369.32 US$5,797,661	15,698 -55.4%	369.32	US$5,797,661
2025-05-13	2025-05-13	PrS Proposed sale	2.5 Foster Jon M Officer Officer	15,698 369.32 US$5,797,660	15,698	369.32	US$5,797,660
2025-02-18	2025-02-14	S Sale	2.7 Berres Jennifer SVP & Chief Human Res. Officer Officer	5,378 -25.9% 322.31 US$1,733,362	5,378 -25.9%	322.31	US$1,733,362
2025-02-18	2025-02-14	S Sale	2.7 Berres Jennifer SVP & Chief Human Res. Officer Officer	4,155 -16.7% 322.96 US$1,341,878	4,155 -16.7%	322.96	US$1,341,878
2025-02-14	2025-02-14	PrS Proposed sale	2.7 Berres Jennifer Officer Officer	9,533 322.59 US$3,075,238	9,533	322.59	US$3,075,238
2025-02-11	2025-02-11	PrS Proposed sale	2.5 Reiner Deborah M Former Officer Officer	3,510 322.39 US$1,131,589	3,510	322.39	US$1,131,589
2025-01-31	2025-01-31	PrS Proposed sale	3.0 Whalen Kathleen M Former Officer Officer	3,228 335.26 US$1,082,203	3,228	335.26	US$1,082,203
2024-11-18	2024-11-14	S Sale	3.0 Whalen Kathleen M SVP & Chief Ethics Officer Officer	1,474 -13.5% 357.99 US$527,677	1,474 -13.5%	357.99	US$527,677
2024-11-14	2024-11-14	PrS Proposed sale	3.0 Whalen Kathleen M Officer Officer	1,474 357.99 US$527,677	1,474	357.99	US$527,677
2024-11-14	2024-11-14	PrS Proposed sale	3.3 Akdamar Erol R Officer Officer	4,872 357.86 US$1,743,480	4,872	357.86	US$1,743,480
2024-11-14	2024-11-14	PrS Proposed sale	Billington Phillip G Officer Officer	3,897 350.00 US$1,363,950	3,897	350.00	US$1,363,950
2024-11-14	2024-11-14	S Sale	3.3 Akdamar Erol R Group President Officer	2,900 -29.8% 353.00 US$1,023,700	2,900 -29.8%	353.00	US$1,023,700
2024-11-14	2024-11-14	PlS Planned sale	Billington Phillip G SVP-Internal Audit Services Officer	3,897 -6.9% 350.00 US$1,363,950	3,897 -6.9%	350.00	US$1,363,950
2024-09-12	2024-09-12	PrS Proposed sale	2.8 Cuffe Michael S. Officer Officer	8,358 385.42 US$3,221,340	8,358	385.42	US$3,221,340
2024-09-12	2024-09-12	PlS Planned sale	2.8 Cuffe Michael S. EVP and Chief Clinical Officer Officer	8,358 -22.0% 385.42 US$3,221,340	8,358 -22.0%	385.42	US$3,221,340
2024-07-31	2024-07-31	PrS Proposed sale	3.0 Whalen Kathleen M Officer Officer	2,987 363.51 US$1,085,804	2,987	363.51	US$1,085,804
2024-07-31	2024-07-31	S Sale	3.0 Whalen Kathleen M SVP & Chief Ethics Officer Officer	2,987 -24.0% 363.51 US$1,085,804	2,987 -24.0%	363.51	US$1,085,804
2024-07-31	2024-07-29	S Sale	3.0 Whalen Kathleen M SVP & Chief Ethics Officer Officer	1,864 -13.0% 359.92 US$670,891	1,864 -13.0%	359.92	US$670,891
2024-07-31	2024-07-29	S Sale	2.5 Reiner Deborah M SVP - Mktg. & Communications Officer	3,314 -48.6% 359.96 US$1,192,914	3,314 -48.6%	359.96	US$1,192,914
2024-07-29	2024-07-29	PrS Proposed sale	2.9 Wyatt Christopher F. Officer Officer	4,000 360.20 US$1,440,783	4,000	360.20	US$1,440,783
2024-07-29	2024-07-29	PrS Proposed sale	2.5 Reiner Deborah M Officer Officer	3,314 359.96 US$1,192,914	3,314	359.96	US$1,192,914
2024-07-29	2024-07-29	PrS Proposed sale	3.0 Whalen Kathleen M Officer Officer	1,864 359.92 US$670,891	1,864	359.92	US$670,891
2024-07-29	2024-07-29	S Sale	2.9 Wyatt Christopher F. SVP & Controller Officer	4,000 -9.0% 360.20 US$1,440,782	4,000 -9.0%	360.20	US$1,440,782
2024-07-29	2024-07-25	S Sale	3.0 Torres Kathryn A. SVP-Payer Contracting & Align. Officer	1,857 -9.5% 355.05 US$659,328	1,857 -9.5%	355.05	US$659,328
2024-07-25	2024-07-25	PrS Proposed sale	3.0 Torres Kathryn A. Officer Officer	1,857 355.05 US$659,328	1,857	355.05	US$659,328
2024-05-20	2024-05-16	S Sale	3.0 Whalen Kathleen M SVP & Chief Ethics Officer Officer	3,204 -25.3% 326.30 US$1,045,465	3,204 -25.3%	326.30	US$1,045,465
2024-05-16	2024-05-16	PrS Proposed sale	3.0 Whalen Kathleen M Officer Officer	3,204 326.30 US$1,045,465	3,204	326.30	US$1,045,465
2024-05-17	2024-05-15	S Sale	3.0 Torres Kathryn A. SVP-Payer Contracting & Align. Officer	1,863 -8.7% 326.18 US$607,673	1,863 -8.7%	326.18	US$607,673
2024-05-15	2024-05-15	PrS Proposed sale	3.0 Torres Kathryn A. Officer Officer	1,863 326.18 US$607,673	1,863	326.18	US$607,673
2024-05-13	2024-05-09	S Sale	1.8 Cohen Jeffrey E. SVP-Government Relations Officer	1,650 -24.1% 313.00 US$516,450	1,650 -24.1%	313.00	US$516,450
2024-05-13	2024-05-09	S Sale	2.8 Cuffe Michael S. EVP and Chief Clinical Officer Officer	6,311 -17.6% 316.88 US$1,999,825	6,311 -17.6%	316.88	US$1,999,825
2024-05-09	2024-05-09	PrS Proposed sale	1.8 Cohen Jeffrey E. Officer Officer	1,650 313.00 US$516,450	1,650	313.00	US$516,450
2024-05-09	2024-05-09	PrS Proposed sale	2.8 Cuffe Michael S. Officer Officer	6,311 316.88 US$1,999,824	6,311	316.88	US$1,999,824
2024-05-07	2024-05-07	PrS Proposed sale	2.8 RUTHERFORD BILL B Former Officer Officer	15,000 311.36 US$4,670,373	15,000	311.36	US$4,670,373
2024-05-08	2024-05-06	PlS Planned sale	2.8 Cuffe Michael S. EVP and Chief Clinical Officer Officer	1,600 -4.5% 309.00 US$494,400	1,600 -4.5%	309.00	US$494,400
2024-05-06	2024-05-06	PrS Proposed sale	2.8 Cuffe Michael S. Officer Officer	1,600 309.00 US$494,400	1,600	309.00	US$494,400
2024-05-06	2024-05-03	S Sale	3.0 Torres Kathryn A. SVP-Payer Contracting & Align. Officer	890 -4.0% 312.00 US$277,680	890 -4.0%	312.00	US$277,680
2024-05-06	2024-05-02	S Sale	3.0 Torres Kathryn A. SVP-Payer Contracting & Align. Officer	973 -4.2% 312.00 US$303,576	973 -4.2%	312.00	US$303,576
2024-05-02	2024-05-02	PrS Proposed sale	3.0 Torres Kathryn A. Officer Officer	1,863 312.00 US$581,256	1,863	312.00	US$581,256
2024-03-20	2024-03-20	PrS Proposed sale	Wasserman Chad J Officer Officer	876 330.25 US$289,299	876	330.25	US$289,299
2024-03-20	2024-03-20	PlS Planned sale	Wasserman Chad J SVP and CIO Officer	876 -35.7% 330.25 US$289,299	876 -35.7%	330.25	US$289,299
2024-03-20	2024-03-18	PlS Planned sale	Wasserman Chad J SVP and CIO Officer	344 -12.3% 321.97 US$110,758	344 -12.3%	321.97	US$110,758
2024-03-18	2024-03-18	PrS Proposed sale	Wasserman Chad J Officer Officer	344 321.97 US$110,758	344	321.97	US$110,758
2024-02-13	2024-02-09	S Sale	3.0 Whalen Kathleen M SVP & Chief Ethics Officer Officer	4,262 -29.4% 306.21 US$1,305,074	4,262 -29.4%	306.21	US$1,305,074
2024-02-09	2024-02-09	PrS Proposed sale	3.0 Whalen Kathleen M Officer Officer	4,262 306.21 US$1,305,074	4,262	306.21	US$1,305,074
2024-02-06	2024-02-06	PrS Proposed sale	2.8 RUTHERFORD BILL B Officer Officer	6,000 310.63 US$1,863,780	6,000	310.63	US$1,863,780
2024-02-06	2024-02-06	S Sale	2.8 RUTHERFORD BILL B CFO and EVP Officer	6,000 -41.5% 310.63 US$1,863,780	6,000 -41.5%	310.63	US$1,863,780
2024-02-07	2024-02-05	S Sale	2.9 Wyatt Christopher F. SVP & Controller Officer	4,000 -9.7% 312.42 US$1,249,680	4,000 -9.7%	312.42	US$1,249,680
2024-02-06	2024-02-05	S Sale	1.5 Mosier Sammie S SVP & Chief Nurse Executive Officer	1,645 -17.7% 312.00 US$513,240	1,645 -17.7%	312.00	US$513,240
2024-02-05	2024-02-05	PrS Proposed sale	2.9 Wyatt Christopher F. Officer Officer	4,000 312.42 US$1,249,680	4,000	312.42	US$1,249,680
2024-02-05	2024-02-05	PrS Proposed sale	1.5 Mosier Sammie S Officer Officer	1,645 312.00 US$513,240	1,645	312.00	US$513,240
2024-02-06	2024-02-02	PlS Planned sale	Wasserman Chad J SVP and CIO Officer	652 -69.2% 312.04 US$203,451	652 -69.2%	312.04	US$203,451
2024-02-02	2024-02-02	PrS Proposed sale	Wasserman Chad J Officer Officer	652 312.04 US$203,451	652	312.04	US$203,451
2024-02-02	2024-01-31	PlS Planned sale	2.8 Cuffe Michael S. EVP and Chief Clinical Officer Officer	3,200 -11.4% 306.79 US$981,734	3,200 -11.4%	306.79	US$981,734
2024-02-02	2024-01-31	S Sale	3.0 Torres Kathryn A. SVP-Payer Contracting & Align. Officer	3,861 -19.5% 307.00 US$1,185,327	3,861 -19.5%	307.00	US$1,185,327